Internal Medicine, Endocrinology, Diabetes, & Metabolism · Riverside, RI
NPI
1740628874
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
375 Wampanoag Trl Ste 202b
Riverside, RI, 02915
Phone (401) 649-4091
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
353 services
Medicare patients, 2024
138
Average age 71
Drug cost, 2024
$1.0M
2,407 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jasmin Lebastchi was code 99214 (office e&m - established), 155 times for 93 patients. In total Jasmin Lebastchi billed 353 services in 14 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 155 | 93 | $85.73 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 86 | 30 | $60.70 | $5,220 |
| 83036 Blood Count | Office | 33 | 23 | $9.52 | $314 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $136.81 | $2,873 |
| 95251 Test - Miscellaneous | Office | 18 | 12 | $27.45 | $494 |
| 99204 Office E&M - New | Office | 14 | 14 | $126.00 | $1,764 |
By year: 2022 $32K for 402 services; 2023 $25K for 324 services; 2024 $26K for 353 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 33 | 23 | $9.52 | $314 |
Medicare prescription drug claims, 2024
In 2024, the drug Jasmin Lebastchi prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 208 prescriptions and refills. In total Jasmin Lebastchi wrote 2,407 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 208 | 394 | 48 | $221K |
| Levothyroxine Sodium Generic | 194 | 431 | 58 | $1,768 |
| Ozempic Semaglutide | 152 | 171 | 29 | $156K |
| Metformin Hcl Er Metformin Hcl | 149 | 315 | 34 | $1,902 |
| Metformin Hcl Generic | 123 | 239 | 29 | $3,780 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 110 | 216 | 30 | $40K |
| Alendronate Sodium Generic | 109 | 289 | 34 | $1,065 |
| Trulicity Dulaglutide | 106 | 156 | 20 | $152K |
| Mounjaro Tirzepatide | 101 | 141 | 22 | $153K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 95 | 215 | 30 | $13K |
| Atorvastatin Calcium Generic | 68 | 140 | 20 | $1,013 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 62 | 119 | 18 | $3,618 |
| Methimazole Generic | 53 | 127 | 14 | $392 |
| Humalog Kwikpen U-100 Insulin Lispro | 52 | 96 | 13 | $9,450 |
| Hydrocortisone Generic | 46 | 71 | Under 11 | $2,648 |
Brand drugs: 1,230 claims; generic drugs: 985 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Jasmin Lebastchi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.